Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort. The gene discussed is CHI3L1; the disease is early-onset autosomal dominant Alzheimer disease.